The symptom: you can't quote the patient in the room
The pricing transparency problem shows up when a patient is ready to start semaglutide or tirzepatide and you cannot state the medication cost because your Promise wholesale tier is not visible in a catalog you can browse before the account is fully set up. You either guess, pad the quote, or promise a follow-up — and follow-ups are where cash-pay conversions stall.
For owners, the same opacity makes margin planning uncertain. If per-vial cost is negotiated through an account manager and can shift with volume tiers, building a predictable cash-pay program means working from estimates rather than numbers until rates appear inside the provider portal.